What is recommended for optimal management of patients with AF according to the European consensus documents?
Dual therapy with OAC plus inhibitor up to 12 mo. Triple therapy up to 6 mo if possible is recommended for optimal management of patients with AF according to the European consensus documents. Additionally, Oral anticoagulant with VKA (TTR >70%) or NOAC, aspirin and clopidogrel should be considered depending on the balance of thrombotic/bleeding risk.